Literature Search

HomeLiterature Search

Popular searches

TP53 BRCA1 CRISPR single-cell cancer

Leng(H),Song(ZX),Liu(Y),Wang(YX),Yang(J),Hu(… Zhonghua Bing Li Xue Za Zhi 2026-03-08

...NF1, SMARCA4, and RET (P<0.05). Transcriptomic analysis demonstrated upregulation of immune-related genes (CCL21, CXCL2)...

Guan(B),Wang(J),Li(X),Lin(L),Fang(D),Kong(W)… Front Oncol 2022-00-00

...NF1 and DICER. We identified approximately 11% of UTUC cases as suspected LS and at least 1.4% patients with confirmed L...

Zambrano(AK),Tamayo-Trujillo(R),Guevara-Ramí… Cancers (Basel) 2026-06-17

...NF1, CYLD, and SDHB. Variants of uncertain significance represented 66.7% of all detected variants and affected several ...

Ghanem(P),Fatteh(M),Kamson(DO),Balan(A),Chan… Front Med (Lausanne) 2023-00-00

...NF1 actionable mutations. Cabozantinib conferred radiographic partial response in two patients harboring a MET and a PDG...

Stockhammer(P),Grant(M),Wurtz(A),Foggetti(G)… J Thorac Oncol 2024-00-00

...NF1, ARID1A, BRCA1, and PTEN) were used to stratify the cohort into the following three subgroups: patients with tumors ...

Kang(J),Kim(EE),Lee(K),Kim(SI),Park(JW),Won(… J Korean Med Sci 2026-03-09

...NF1 (64%), ATRX (52%), PTPN11 (28%), FGFR1/FGFR4 (20%), TERTp (16%), and TP53 (16%). Patients with HGAP had significantl...

Tesser-Gamba(F),Mendes(TB),Lima(FT),Abib(SCV… Int J Mol Sci 2026-08-12

...NF1, DICER1, SMARCA4, PTEN, and PIK3CA, were also detected. Importantly, molecular profiling had significant diagnostic ...

Urbas(A),Ušaj(P),Šeruga(B),Krajc(M),Hotujec(… Hered Cancer Clin Pract 2026-04-15

...NF1, RET and BRCA2 genes. In 61.9% (13/21) of positive cases, an identified cancer predisposition syndrome was linked to...

Fagbohun(OF),Oladipo(AO),Gao(C),Olawoye(B),B… Cell Death Discov 2026-04-10

...NF1, and CHEK2) and deciphered the functional consequences leveraging the higher throughput Illumina NovaSeq X and NextS...

Yao(ZG),Li(XL),Wen(WJ),Lin(XY),Zhang(GH),Sun… Acta Neuropathol Commun 2026-03-05

...NF1 (64.3%, 18/28), along with activating mutations in PDGFRA (39.3%, 11/28) and EGFR (32.1%, 9/29), suggesting tumor pr...

Previous 884 885 886 887 888 889 890 891 892 Next Vol. 888 / of 895 页